Improvement of cisplatin-related renal dysfunction by synthetic ghrelin: a prospective randomised phase II trial

BACKGROUND: Ghrelin, a 28-amino acid peptide predominantly produced by the stomach, exerts powerful renal protective effects by increasing levels of insulin-like growth factor-1 (IGF-1). The aim of this study was to evaluate the effects of ghrelin on the incidence of renal dysfunction in patients re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Yanagimoto, Yoshitomo, Takiguchi, Shuji, Miyazaki, Yasuhiro, Makino, Tomoki, Takahashi, Tsuyoshi, Kurokawa, Yukinori, Yamasaki, Makoto, Miyata, Hiroshi, Nakajima, Kiyokazu, Hosoda, Hiroshi, Kangawa, Kenji, Mori, Masaki, Doki, Yuichiro
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984476/
https://ncbi.nlm.nih.gov/pubmed/27253174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.160
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars